Medmix AG (CHIX:MEDXZ) Other Stockholders Equity: CHF-57.2 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CHIX:MEDXZ Medmix AG CHIX:MEDXZ
66 GF Score
Price CHF8.54
GF Value CHF9.05
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Medmix AG Other Stockholders Equity?

Medmix AG CHIX:MEDXZ +1.97% 66 Other Stockholders Equity is CHF-57.2 Mil as of Jun. 2026. GuruFocus rates CHIX:MEDXZ with a GF Score™ of 66/100 and a GF Value™ of CHF9.05 (Fairly Valued). The stock has 6 warning signs investors should review.

Medmix AG's Other Stockholders Equity for the quarter that ended in Jun. 2026 was CHF-57.2 Mil.

Medmix AG's quarterly Other Stockholders Equity declined from Jun. 2025 (CHF-54.1 Mil) to Dec. 2025 (CHF-57.1 Mil) and declined from Dec. 2025 (CHF-57.1 Mil) to Jun. 2026 (CHF-57.2 Mil).

Medmix AG's annual Other Stockholders Equity increased from Dec. 2023 (CHF-49.6 Mil) to Dec. 2024 (CHF-48.4 Mil) but then declined from Dec. 2024 (CHF-48.4 Mil) to Dec. 2025 (CHF-57.1 Mil).

Medmix AG Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Medmix AG's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medmix AG Other Stockholders Equity Chart

Medmix AG Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Stockholders Equity
Get a 7-Day Free Trial 533.50 -23.40 -49.60 -48.40 -57.10

Medmix AG Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -36.60 -48.40 -54.10 -57.10 -57.20
CHIX:MEDXZ
66GF Score
Medmix AG CHIX:MEDXZ
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medmix AG Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of CHF-57.2 Mil mean?
Medmix AG (CHIX:MEDXZ) has a Other Stockholders Equity of CHF-57.2 Mil as of Jun. 2026. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Medmix AG and its competitors.
Is Medmix AG's Other Stockholders Equity too high?
Medmix AG's current Other Stockholders Equity is CHF-57.2 Mil. Overall, Medmix AG has a GF Score™ of 66/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Medmix AG's Other Stockholders Equity compare to GEV and ETN?
Medmix AG's Other Stockholders Equity of CHF-57.2 Mil can be compared against companies in the Industrial Products industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for an Industrial Products company?
A good Other Stockholders Equity depends on the Industrial Products industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Medmix AG and its competitors. Medmix AG's current Other Stockholders Equity is CHF-57.2 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medmix AG stock overvalued right now?
Based on GuruFocus' analysis, Medmix AG (CHIX:MEDXZ) is currently considered Fairly Valued. The stock's GF Value™ is CHF9.05, compared to a current price of CHF8.54 — trading 5.7% below its estimated fair value. The current Other Stockholders Equity is CHF-57.2 Mil. Medmix AG's overall GF Score™ is 66/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Medmix AG (CHIX:MEDXZ), the current Other Stockholders Equity is CHF-57.2 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medmix AG (CHIX:MEDXZ) Overvalued in 2026?

Based on GuruFocus' analysis, Medmix AG stock appears to be undervalued. The current stock price of CHF8.54 is trading 5.7% below its estimated GF Value™ of CHF9.05. GuruFocus considers Medmix AG to be Fairly Valued.

Key valuation signals for CHIX:MEDXZ:

  • Other Stockholders Equity: CHF-57.2 Mil
  • GF Value™: CHF9.05 vs. price of CHF8.54 (5.7% below fair value)
  • GF Score™: 66/100 with 6 warning signs

No single metric tells the full story. See the CHIX:MEDXZ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Medmix AG Business Description

Other Exchanges MEDX:Switzerland
Address Neuhofstrasse 20, Baar, CHE, 6340
Medmix AG designs and produces high-precision delivery devices for the healthcare, consumer and industrial segments. Its segments are Healthcare, Consumer & Industrial, and Others. The Healthcare segment focuses on delivery devices for the drug delivery, surgery, and dental markets, including injection pens for subcutaneous drug delivery, surgical delivery devices, and mixing and delivery systems for the dental consumable industry. The Consumer & Industrial segment focuses on delivery devices used for industrial applications such as adhesives in construction, electronics, automotive, and aerospace, as well as consumer markets such as beauty and microbrush applications. The company operates in Europe, the Middle East and Africa, the Americas, and Asia-Pacific.
66GF Score

Get the complete analysis for CHIX:MEDXZ

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF8.54
Price
CHF9.05
GF Value